Sildenafil G.L. Pharma

Medicinal product

(Invented) name

Sildenafil G.L. Pharma

Active substance (s)

Sildenafilis

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE03, Sildenafil

Marketing authorisation holder

G.L. Pharma GmbH, Austrija

Date of authorisation

2023-03-28

Date of renewal

Documents

5157 Pakuotės lapelis 2025 01 18.docx

5157 Sildenafil GL Pharma RPP 2025 01 18.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

AT/H/1224/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Sildenafilis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110695	96806	1096806	lizdinė plokštelė	N90		Receptinis	LT/1/23/5157/001	Netiekiama	-	-	No	-	-
110696	96807	1096807	lizdinė plokštelė	N300		Receptinis	LT/1/23/5157/002	Netiekiama	-	-	No	-	-
110697	96808	1096808	dalomoji lizdinė plokštelė	N90×1		Receptinis	LT/1/23/5157/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-03-28	Registruotas